As the weather becomes cooler and the holidays draw near, we pause and offer a moment of gratitude to you. Thank you for standing up for cancer care in Maine. Because of your support, we are changing the landscape of this disease in our state.
PORTLAND, Maine — The Bristol-Myers Squibb Foundation has awarded a $5 million grant to Maine Medical Center (MMC) for the creation of a statewide initiative to improve the prevention, early detection and treatment of lung cancer in Maine, where incidence rates and deaths due to lung cancer are among the highest in the nation, according to the Centers for Disease Control and Prevention.
The Maine Lung Cancer Prevention and Screening (Maine LungCAPS) Initiative is a four-year multi-institution, multi-disciplinary collaboration of Maine health care providers and stakeholders.
$5.6 million grant award to create state-wide prevention and screening program
There is a harsh reality facing the people of Maine: local lung cancer rates are among the highest in the nation and the leading cause of cancer deaths in the state. For years, an ad-hoc network of isolated programs have struggled to make improvements, but one Maine physician is ready to take on the entire spectrum of cancer screening, prevention and treatment in a bid save move lives.